Literature DB >> 26390160

Massive transfusion: red blood cell to plasma and platelet unit ratios for resuscitation of massive hemorrhage.

Colin H Murphy1, John R Hess.   

Abstract

PURPOSE OF REVIEW: The aim of this short study is to review recently published data bearing on how to resuscitate massive uncontrolled hemorrhage. RECENT
FINDINGS: New data inform our understanding of the mechanisms of the acute coagulopathy of trauma, the median time to death of trauma patients with uncontrolled hemorrhage, the effects of blood product composition on the coagulation capacity of infused resuscitation mixtures, the outcomes of patients resuscitated according to common massive transfusion protocols in clinical situations associated with massive hemorrhage, and who might benefit from balanced, blood-product-based resuscitation. Importantly, the trial methods, blood bank methods, and primary outcomes of the Pragmatic Randomized Optimal Plasma and Platelet Ratios (PROPPR) trial were recently published. Resuscitation with a 1 : 1 : 1 ratio of units of plasma and platelets to red blood cells was well tolerated and reduced hemorrhagic mortality during resuscitation in the PROPPR trial.
SUMMARY: The bulk of currently available data support the use of a 1 : 1 : 1 ratio for the resuscitation of patients with severe injury, shock, and uncontrolled hemorrhage. The application of this formulaic approach to massive blood product-based resuscitation in other clinical situations is less well supported in the literature.

Entities:  

Mesh:

Year:  2015        PMID: 26390160     DOI: 10.1097/MOH.0000000000000184

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  5 in total

1.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.

Authors:  Lisa L Strate; Ian M Gralnek
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

2.  Microparticles from aged packed red blood cell units stimulate pulmonary microthrombus formation via P-selectin.

Authors:  Young Kim; Michael D Goodman; Andrew D Jung; William A Abplanalp; Rebecca M Schuster; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts
Journal:  Thromb Res       Date:  2019-11-26       Impact factor: 3.944

3.  The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients.

Authors:  Mathijs R Wirtz; Daisy V Schalkers; J Carel Goslings; Nicole P Juffermans
Journal:  Transfusion       Date:  2020-06-24       Impact factor: 3.157

4.  mTICCS and its inter-rater reliability to predict the need for massive transfusion in severely injured patients.

Authors:  Klemens Horst; Philipp Lichte; Felix Bläsius; Christian David Weber; Martin Tonglet; Philipp Kobbe; Nicole Heussen; Frank Hildebrand
Journal:  Eur J Trauma Emerg Surg       Date:  2020-10-14       Impact factor: 3.693

5.  Validation of the mTICCS Score as a Useful Tool for the Early Prediction of a Massive Transfusion in Patients with a Traumatic Hemorrhage.

Authors:  Klemens Horst; Rachel Lentzen; Martin Tonglet; Ümit Mert; Philipp Lichte; Christian D Weber; Philipp Kobbe; Nicole Heussen; Frank Hildebrand
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.